Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial

Authors: Zhi‐Wei Lai, Ryan L. Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcı́a, Hajra Tily, Lisa Francis, Stephen V. Faraone, Paul E. M. Phillips, András Perl - The Lancet 2018 cited by 401